- Report
- February 2024
- 96 Pages
Global
From €3500EUR$4,013USD£3,065GBP
- Report
- April 2025
- 50 Pages
Global
From €2476EUR$2,650USD£2,094GBP
Benproperine Phosphate is a respiratory drug used to treat bronchial asthma, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. It is a long-acting beta-2 agonist (LABA) that works by relaxing the muscles of the airways, allowing more air to flow in and out of the lungs. Benproperine Phosphate is available in both oral and inhalation forms, and is often used in combination with other medications to provide better symptom control. It is generally well-tolerated, with the most common side effects being headache, nausea, and throat irritation.
Benproperine Phosphate is a widely used drug in the respiratory market, and is available from many pharmaceutical companies. Some of the major players in the market include GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more